22 resultaten gevonden
Publicaties Kim De Rycke | Kim De Rycke | Universiteit Antwerpen
Kim De Rycke onbezoldigd medewerker Publicaties Kim De Rycke Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma : protocol of a monocentric phase I/II clinical trial in …
Publications Manon Huizing | Manon Huizing | University of Antwerp
Manon Huizing unpaid staff Publications Manon Huizing Molecular imaging for early response assessment of neo-adjuvant chemotherapy and drugs targeting the PI3K/Akt/mTOR pathway in HER-2 amplified breast cancer Source Antwerp, University of Antwerp, 2024,223 p. Author(s) Yanina Dockx, Sigrid Strooban…
Publicaties Manon Huizing | Manon Huizing | Universiteit Antwerpen
Manon Huizing onbezoldigd medewerker Publicaties Manon Huizing Molecular imaging for early response assessment of neo-adjuvant chemotherapy and drugs targeting the PI3K/Akt/mTOR pathway in HER-2 amplified breast cancer Bron Antwerp, University of Antwerp, 2024,223 p. Auteur(s) Yanina Dockx, Sigrid S…
Publicaties Stephanie Vanden Bossche | Stephanie Vanden Bossche | Universiteit Antwerpen
Stephanie Vanden Bossche onbezoldigd medewerker Publicaties Stephanie Vanden Bossche A pediatric case of fusobacterium necrophorum mastoiditis and meningitis case report in a healthy child and review of the literature Bron Case Reports in Pediatrics - ISSN 2090-6803-12 (2024) p. Auteur(s) Elizabeth …
Publications Sébastien Anguille | Sébastien Anguille | University of Antwerp
Sébastien Anguille associate professor - fund. clinical researcher Publications Sébastien Anguille Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives Source EJHaem - ISSN 2688-6146-5:5 (2024) p. 1096-1099 Author(s) Bert Heyrman, Stef Meers, Seli…
Publications Jolien Van den Bossche | Jolien Van den Bossche | University of Antwerp
Jolien Van den Bossche unpaid staff Publications Jolien Van den Bossche Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Source PLoS ON…
Publications Maxime De Laere | Maxime De Laere | University of Antwerp
Maxime De Laere senior researcher Publications Maxime De Laere Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Source PLoS ONE - ISSN …
Publications Zwi Berneman | Zwi Berneman | University of Antwerp
Zwi Berneman emeritus with assignment Publications Zwi Berneman Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed Source Annals of hematology - ISSN 0939-5555- (2024) p. Author(s) Sofie Gielis, Donovan Flume…
Publicaties Sébastien Anguille | Sébastien Anguille | Universiteit Antwerpen
Sébastien Anguille hoofddocent - fundamenteel klinisch navorser Publicaties Sébastien Anguille Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives Bron EJHaem - ISSN 2688-6146-5:5 (2024) p. 1096-1099 Auteur(s) Bert Heyrman, Stef Meers, Selim Sid,…
Publicaties Jolien Van den Bossche | Jolien Van den Bossche | Universiteit Antwerpen
Jolien Van den Bossche onbezoldigd medewerker Publicaties Jolien Van den Bossche Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Bron …
Publicaties Maxime De Laere | Maxime De Laere | Universiteit Antwerpen
Maxime De Laere senior onderzoeker Publicaties Maxime De Laere Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Bron PLoS ONE - ISSN 19…
Publications Barbara Stein | Barbara Stein | University of Antwerp
Barbara Stein unpaid staff Publications Barbara Stein Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Source PLoS ONE - ISSN 1932-6203…
Publications Eva Lion | Eva Lion | University of Antwerp
Eva Lion assistant professor - senior researcher Publications Eva Lion Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed Source Annals of hematology - ISSN 0939-5555- (2024) p. Author(s) Sofie Gielis, Donova…
Publications Marie Couttenye | Marie Couttenye | University of Antwerp
Marie Couttenye emeritus occasional assignment Publications Marie Couttenye Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients : IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination Source Virology journal - ISSN 1743-422X-21:1 (2024) p. 1-14 Au…
Publications Ella Roelant | Ella Roelant | University of Antwerp
Ella Roelant unpaid staff Publications Ella Roelant Treatment for preschool age children who stutter : protocol of a randomised, non-inferiority parallel group pragmatic trial with Mini-KIDS, social cognitive behaviour treatment and the Lidcombe Program-TreatPaCS Source PLoS ONE - ISSN 1932-6203-19:…
Publicaties Zwi Berneman | Zwi Berneman | Universiteit Antwerpen
Zwi Berneman emeritus met opdracht Publicaties Zwi Berneman Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed Bron Annals of hematology - ISSN 0939-5555- (2024) p. Auteur(s) Sofie Gielis, Donovan Flumens, Sa…
Publicaties Marie Couttenye | Marie Couttenye | Universiteit Antwerpen
Marie Couttenye emeritus occasionele opdracht Publicaties Marie Couttenye Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients : IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination Bron Virology journal - ISSN 1743-422X-21:1 (2024) p. 1-14 Auteur…
Publicaties Barbara Stein | Barbara Stein | Universiteit Antwerpen
Barbara Stein onbezoldigd medewerker Publicaties Barbara Stein Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Bron PLoS ONE - ISSN 19…
Publicaties Eva Lion | Eva Lion | Universiteit Antwerpen
Eva Lion docent - senior onderzoeker Publicaties Eva Lion Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed Bron Annals of hematology - ISSN 0939-5555- (2024) p. Auteur(s) Sofie Gielis, Donovan Flumens, Sann…
Publicaties Ella Roelant | Ella Roelant | Universiteit Antwerpen
Ella Roelant onbezoldigd medewerker Publicaties Ella Roelant Treatment for preschool age children who stutter : protocol of a randomised, non-inferiority parallel group pragmatic trial with Mini-KIDS, social cognitive behaviour treatment and the Lidcombe Program-TreatPaCS Bron PLoS ONE - ISSN 1932-6…
Publications Griet Nijs | Griet Nijs | University of Antwerp
Griet Nijs unpaid staff Publications Griet Nijs Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Source PLoS ONE - ISSN 1932-6203-19:7 …
Publicaties Griet Nijs | Griet Nijs | Universiteit Antwerpen
Griet Nijs onbezoldigd medewerker Publicaties Griet Nijs Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Bron PLoS ONE - ISSN 1932-620…